The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more
We are pleased to make available to you our quarterly update on dealmaking market trends and legal developments for Fourth Quarter 2012....more